Aytu BioPharma, Inc. (LON:0A8M)

Aytu BioPharma Revenue

Aytu BioPharma had revenue of $18.45M USD in the quarter ending March 31, 2025, with 31.57% growth. This brings the company's revenue in the last twelve months to $81.66M, up 0.41% year-over-year. In the fiscal year ending June 30, 2024, Aytu BioPharma had annual revenue of $81.00M, down -24.58%.

• Revenue (ttm): $81.66M
• Revenue Growth: +0.41%
• P/S Ratio: 0.24
• Revenue / Employee: $800.58K
• Employees: 102
• Market Cap: 15.24M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	81.00M	-26.40M	-24.58%
Jun 30, 2023	107.40M	10.73M	11.10%
Jun 30, 2022	96.67M	31.04M	47.29%
Jun 30, 2021	65.63M	38.00M	137.52%
Jun 30, 2020	27.63M	20.31M	277.47%